Bifurcation and Stability of a Mathematical Model for Tumor Growth with Oncolytic Virotherapy

被引:0
|
作者
Chen, Hong-Bing [1 ,2 ]
机构
[1] Northwest Normal Univ, Sch Math & Stat, Lanzhou 730070, Gansu, Peoples R China
[2] Tianshui Normal Univ, Sch Math & Stat, Tianshui 741001, Gansu, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Oncolytic virotherapy; T-OV-taxis; global bifurcation; stability; REACTION-DIFFUSION MODEL; DYNAMICS; VIRUS; ADENOVIRUS; EFFICACY; THERAPY; CELLS;
D O I
10.1142/S0218127423501687
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Replication-competent viruses have been used as an alternative therapeutic approach for cancer treatment. In this paper, a T-OV-taxis mathematical model for tumor growth with oncolytic virotherapy is established. First, the stability of u* is studied in the ODE system and in the reaction-diffusion system of the model. It is found that the stability of u* will not be changed by diffusion alone. Next, the T-OV-taxis rate chi is selected as a bifurcation factor, and a threshold value chi(0) (chi(0) < 0) is found, such that positive constant steady-state u* becomes unstable when chi < chi(0). Hence, the taxis-driven Turing instability occurs. Furthermore, the existence, stability, turning direction of steady-state bifurcation are discussed. And, the local steady-state bifurcation is extended to a global one, where the theory used is the Crandall-Rabinowitz bifurcation theorem. Finally, it is concluded that T-OV-taxis rate chi plays an important role in this mathematical model.
引用
下载
收藏
页数:26
相关论文
共 50 条
  • [21] A mathematical model that combines chemotherapy and oncolytic virotherapy as an alternative treatment against a glioma
    Urenda-Cazares, E.
    Gallegos, A.
    Macias-Diaz, J. E.
    JOURNAL OF MATHEMATICAL CHEMISTRY, 2020, 58 (03) : 544 - 554
  • [22] Transforming the prostatic tumor microenvironment with oncolytic virotherapy
    Atherton, Matthew J.
    Stephenson, Kyle B.
    Tzelepis, Fanny
    Bakhshinyan, David
    Nikota, Jake K.
    Son, Hwan Hee
    Jirovec, Anna
    Lefebvre, Charles
    Dvorkin-Gheva, Anna
    Ashkar, Ali A.
    Wan, Yonghong
    Stojdl, David F.
    Belanger, Eric C.
    Breau, Rodney H.
    Bell, John C.
    Saad, Fred
    Singh, Sheila K.
    Diallo, Jean-Simone
    Lichty, Brian D.
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [23] Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
    Enow, Junior A.
    Sheikh, Hummad I.
    Rahman, Masmudur M.
    VIRUSES-BASEL, 2023, 15 (11):
  • [24] Stability analysis of a fractional-order delay dynamical model on oncolytic virotherapy
    Singh, Hitesh K.
    Pandey, Dwijendra N.
    MATHEMATICAL METHODS IN THE APPLIED SCIENCES, 2021, 44 (02) : 1377 - 1393
  • [25] Hopf bifurcation analysis of a tumor virotherapy model with two time delays
    Li, Hui-zhong
    Liu, Xiang-dong
    Yan, Rui
    Liu, Cheng
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2020, 553
  • [26] The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study
    Pooladvand, Pantea
    Yun, Chae-Ok
    Yoon, A-Rum
    Kim, Peter S.
    Frascoli, Federico
    MATHEMATICAL BIOSCIENCES, 2021, 334
  • [27] Fractional time-delay mathematical modeling of Oncolytic Virotherapy
    Kumar, Pushpendra
    Erturk, Vedat Suat
    Yusuf, Abdullahi
    Kumar, Sunil
    CHAOS SOLITONS & FRACTALS, 2021, 150
  • [28] Bifurcation of a Mathematical Model for Tumor Growth with Angiogenesis and Gibbs-Thomson Relation
    Xu, Shihe
    Bai, Meng
    Zhang, Fangwei
    INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS, 2021, 31 (15):
  • [29] THE REPLICABILITY OF ONCOLYTIC VIRUS: DEFINING CONDITIONS IN TUMOR VIROTHERAPY
    Tian, Jianjun Paul
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2011, 8 (03) : 841 - 860
  • [30] Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
    Zhang, Yuhui
    Liu, Zhuoming
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (40) : 4251 - 4263